↓ Skip to main content

Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

Overview of attention for article published in BMC Infectious Diseases, March 2006
Altmetric Badge

Mentioned by

wikipedia
8 Wikipedia pages

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine
Published in
BMC Infectious Diseases, March 2006
DOI 10.1186/1471-2334-6-65
Pubmed ID
Authors

Neelam Pasricha, Usha Datta, Yogesh Chawla, Surjit Singh, Sunil K Arora, Archana Sud, Ranjana W Minz, Biman Saikia, Haqeeqat Singh, Isaac James, Shobha Sehgal

Abstract

Patients with HIV infection are at risk of co-infection with HBV, as the routes of transmission are shared and thus immunization with HBV vaccine could be protective in them. The aim of the present study was to assess the efficacy of recombinant vaccine in treatment-naive HIV positive patients and healthy controls, and to dissect out differences if any, in different limbs of immune response.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
United States 1 2%
Unknown 47 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 16%
Student > Ph. D. Student 7 14%
Student > Master 6 12%
Professor 5 10%
Student > Postgraduate 5 10%
Other 12 24%
Unknown 6 12%
Readers by discipline Count As %
Medicine and Dentistry 20 41%
Agricultural and Biological Sciences 14 29%
Immunology and Microbiology 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 2 4%
Unknown 8 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 June 2023.
All research outputs
#7,453,827
of 22,787,797 outputs
Outputs from BMC Infectious Diseases
#2,538
of 7,671 outputs
Outputs of similar age
#23,232
of 66,233 outputs
Outputs of similar age from BMC Infectious Diseases
#5
of 14 outputs
Altmetric has tracked 22,787,797 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,671 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 66,233 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.